Joshua Wethli
Nurse Practitioner · Harrisburg, PANPI 1063710911
Payments from drug & device makers
Across 134 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$597
- Novo Nordisk$416
- Lilly USA, LLC$272
- GSK$230
- AstraZeneca$140
- Pfizer$95
- plus $536 from 15 others
What the payments were for
- Food & beverage$2,27599%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $597 |
| Novo Nordisk | 26 | $416 |
| Lilly USA, LLC | 15 | $272 |
| GSK | 12 | $230 |
| AstraZeneca | 10 | $140 |
| Pfizer | 6 | $95 |
| Merck | 6 | $95 |
| Astellas Pharma US Inc | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| Exact Sciences | 3 | $62 |
| Johnson & Johnson | 2 | $39 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Amgen | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$2,286 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 32 | $43,190 |
| EliquisApixaban | 13 | $19,651 |
| FarxigaDapagliflozin Propanediol | 18 | $18,696 |
| TrulicityDulaglutide | 15 | $17,500 |
| RybelsusSemaglutide | 17 | $15,861 |
| Atorvastatin Calcium | 114 | $2,003 |
| Rosuvastatin Calcium | 42 | $952 |
| Tamsulosin Hcl | 28 | $725 |
| Levothyroxine Sodium | 75 | $675 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 12 | $659 |
| Lisinopril | 76 | $640 |
| Losartan Potassium | 60 | $621 |
| SynthroidLevothyroxine Sodium | 12 | $620 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $613 |
| Metformin Hcl ErMetformin Hcl | 34 | $601 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $416 | $59,05149 claims |
| PfizerEliquis | $95 | $19,65113 claims |
| AstraZenecaFarxiga | $140 | $18,69618 claims |
| Lilly USA, LLCTrulicity | $272 | $17,50015 claims |
| AbbVieSynthroid | $597 | $62012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Harrisburg
- Ryan HornungHarrisburg$18K
- Barbara LittleHarrisburg$12K
- Jodi JohnsonHarrisburg$11K
- Tatyana BelimovaHarrisburg$10K
- Gina KoonsHarrisburg$10K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.